A recent blood-based hepatitis C virus assay on Nuclein's DASH system highlighted its on-device sample prep, among other features that have been driving its adoption.
With a growing number of exosome-based delivery vehicles advancing into the clinic for therapeutics and vaccines, more effective isolation and separation strategies are needed. Finnish researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback